Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20683334 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparison of Org 25969 With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (19.4.301)(P05960)(COMPLETED)
Condition: Anesthesia, General
Interventions: Drug: Sugammadex;   Drug: neostigmine

Indicates status has not been verified in more than two years